Suppr超能文献

无药物银三角纳米棱镜治疗性探针等离子体行为的计算分析,用于原位肿瘤成像和光热治疗。

Computational analysis of drug free silver triangular nanoprism theranostic probe plasmonic behavior for in-situ tumor imaging and photothermal therapy.

机构信息

New-senior Healthcare Innovation Center (BK21 Plus), Pukyong National University, Busan 48513, Republic of Korea.

Department of Physics and Astronomy, The University of Texas at San Antonio, One UTSA Circle, San Antonio, Texas 78249, United States.

出版信息

J Adv Res. 2022 Nov;41:23-38. doi: 10.1016/j.jare.2022.02.006. Epub 2022 Feb 17.

Abstract

INTRODUCTION

The advanced features of plasmonic nanomaterials enable initial high accuracy detection with different therapeutic intervention. Computational simulations could estimate the plasmonic heat generation with a high accuracy and could be reliably compared to experimental results. This proposed combined theoretical-experimental strategy may help researchers to better understand other nanoparticles in terms of plasmonic efficiency and usability for future nano-theranostic research.

OBJECTIVES

To develop innovative computationally-driven approach to quantify any plasmonic nanoparticles photothermal efficiency and effects before their use as therapeutic agents.

METHODS

This report introduces drug free plasmonic silver triangular nanoprisms coated with polyvinyl alcohol biopolymer (PVA-SNT), for in vivo photoacoustic imaging (PAI) guided photothermal treatment (PTT) of triple-negative breast cancer mouse models. The synthesized PVA-SNT nanoparticles were characterized and a computational electrodynamic analysis was performed to evaluate and predict the optical and plasmonic photothermal properties. The in vitro biocompatibility and in vivo tumor abalation study was performed with MDA-MB-231 human breast cancer cell line and in nude mice model.

RESULTS

The drug free 140 μg∙mL PVA-SNT nanoparticles with 1.0 W∙cm laser irradiation for 7 min proved to be an effective and optimized theranostic approach in terms of PAI guided triple negative breast cancer treatment. The PVA-SNT nanoparticles exhibits excellent biosafety, photostability, and strong efficiency as PAI contrast agent to visualize tumors. Histological analysis and fluorescence-assisted cell shorter assay results post-treatment apoptotic cells, more importantly, it shows substantial damage to in vivo tumor tissues, killing almost all affected cells, with no recurrence.

CONCLUSION

This is a first complete study on computational simulations to estimate the plasmonic heat generation followed by drug free plasmonic PAI guided PTT for cancer treatment. This computationally-driven theranostic approach demonstrates an innovative thought regarding the nanoparticles shape, size, concentration, and composition which could be useful for the prediction of photothermal heat generation in precise nanomedicine applications.

摘要

简介

等离子体纳米材料的先进特性使不同治疗干预的初始高精度检测成为可能。计算模拟可以高精度地估计等离子体的发热情况,并且可以与实验结果可靠地进行比较。这种拟议的理论与实验相结合的策略可能有助于研究人员更好地理解其他纳米粒子的等离子体效率和在未来纳米治疗研究中的可用性。

目的

开发创新的计算驱动方法,在将等离子体纳米粒子用作治疗剂之前,定量评估任何等离子体纳米粒子的光热效率和效果。

方法

本报告介绍了一种无药物的等离子体银三角纳米棱柱体,其表面涂有聚乙烯醇生物聚合物(PVA-SNT),用于三阴性乳腺癌小鼠模型的体内光声成像(PAI)引导光热治疗(PTT)。合成的 PVA-SNT 纳米粒子进行了表征,并进行了计算电动力学分析,以评估和预测其光学和等离子体光热性质。无药物的 140μg·mL PVA-SNT 纳米粒子的体外生物相容性和体内肿瘤消融研究是在 MDA-MB-231 人乳腺癌细胞系和裸鼠模型中进行的。

结果

在 1.0 W·cm 的激光照射下,浓度为 140μg·mL 的无药物 PVA-SNT 纳米粒子照射 7 分钟,被证明是一种有效的、优化的治疗方法,可用于 PAI 引导的三阴性乳腺癌治疗。PVA-SNT 纳米粒子表现出优异的生物安全性、光稳定性和作为 PAI 对比剂的强大效率,可用于肿瘤可视化。治疗后,组织学分析和荧光辅助细胞缩短试验结果显示凋亡细胞增多,更重要的是,它显示对体内肿瘤组织有实质性损伤,几乎杀死了所有受影响的细胞,且无复发。

结论

这是首次对计算模拟进行全面研究,以估计等离子体的发热情况,然后进行无药物的等离子体 PAI 引导的 PTT 以治疗癌症。这种计算驱动的治疗方法展示了一种关于纳米粒子形状、大小、浓度和组成的创新思想,这对于在精确的纳米医学应用中预测光热发热可能是有用的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8444/9637560/f2eb200e40e9/ga1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验